Compound 923
Identifiers
- Canonical SMILES:
CNC(=O)c1cc(OC)c(O[C@@H](C)C(=O)N2CCN(C[C@H]2C)c2nccn2CC2CC2)cn1
- IUPAC name:
5-[(2S)-1-[(2R)-4-[1-(cyclopropylmethyl)imidazol-2-yl]-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-4-methoxy-N-methylpyridine-2-carboxamide
- InChi:
InChI=1S/C23H32N6O4/c1-15-13-28(23-25-7-8-27(23)14-17-5-6-17)9-10-29(15)22(31)16(2)33-20-12-26-18(21(30)24-3)11-19(20)32-4/h7-8,11-12,15-17H,5-6,9-10,13-14H2,1-4H3,(H,24,30)/t15-,16+/m1/s1
- InChiKey:
CBFBVKRYRFGNRU-CVEARBPZSA-N
External links
45487301 |
CHEMBL571424 |
24634282 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 5.72 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 456.25 g/mol | |||
HBA | 10 | |||
HBD | 1 | |||
HBA + HBD | 11 | |||
AlogP | 1.31 | |||
TPSA | 101.82 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4470 | 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide | DB06938 | |
0.4387 | Atevirdine | DB12264 | |
0.4286 | Doxazosin | DB00590 | |
0.4229 | 1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE | DB08590 | |
0.4180 | Gepotidacin | DB12134 | |
0.4171 | Pozanicline | DB05458 | |
0.4074 | Terazosin | DB01162 | |
0.4035 | Lecozotan | DB12540 | |
0.4015 | Rebastinib | DB13005 | |
0.3939 | N,N-[2,5-O-dibenzyl-glucaryl]-DI-[valinyl-aminomethanyl-pyridine] | DB03803 | |
0.3934 | CM-4307 | DB15414 | |
0.3934 | Sorafenib | DB00398 | |
0.3894 | 5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide | DB03288 | |
0.3891 | [4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium | DB02269 | |
0.3889 | Dabigatran | DB14726 |